BANK OF AMERICA CORP /DE/ - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 89 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$76,850
-5.5%
44,680
+7.2%
0.00%
Q2 2023$81,290
-97.2%
41,687
-96.1%
0.00%
Q1 2023$2,947,462
+577.6%
1,060,238
+740.9%
0.00%
Q4 2022$435,007
+206.3%
126,089
+128.3%
0.00%
Q3 2022$142,000
+118.5%
55,237
+106.6%
0.00%
Q2 2022$65,000
-79.0%
26,737
-64.4%
0.00%
Q1 2022$310,000
-89.6%
75,181
-67.7%
0.00%
Q4 2021$2,989,000
+1228.4%
232,412
+1013.9%
0.00%
Q3 2021$225,000
+80.0%
20,864
+51.5%
0.00%
Q2 2021$125,000
-68.0%
13,776
-66.8%
0.00%
Q1 2021$391,000
+768.9%
41,481
+263.3%
0.00%
Q4 2020$45,000
-59.5%
11,419
-72.6%
0.00%
Q3 2020$111,000
-16.5%
41,746
+108.2%
0.00%
Q2 2020$133,000
-10.1%
20,047
-21.3%
0.00%
Q1 2020$148,000
-14.9%
25,474
+31.2%
0.00%
Q4 2019$174,000
+31.8%
19,409
+27.1%
0.00%
Q3 2019$132,000
-3.6%
15,275
+23.2%
0.00%
Q2 2019$137,000
+407.4%
12,396
+496.5%
0.00%
Q1 2019$27,000
-40.0%
2,078
-27.3%
0.00%
Q4 2018$45,0002,8590.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders